Advanced search
Publication Cover
Cancer Biology & Therapy Volume 13, 2012 - Issue 9
Submit an article Journal homepage
1,661
Views
21
CrossRef citations to date
0
Altmetric
Research Paper

The anti-Fn14 antibody BIIB036 inhibits tumor growth in xenografts and patient derived primary tumor models and enhances efficacy of chemotherapeutic agents in multiple xenograft models

Jennifer S. Michaelson Biogen Idec; Cambridge, MA USACorrespondence[email protected]
,
Rebecca Kelly Biogen Idec; Cambridge, MA USA
,
Lu Yang Sanofi, Inc.; Cambridge, MA USA
,
Xiamei Zhang Novartis Institute for Biomedical Research; Cambridge, MA USA
,
Kathleen Wortham Dicerna Pharmaceuticals, Inc.; Watertown, MA USA
&
Ingrid B.J.K. Joseph Agensys, an affiliate of Astellas Pharma, Inc.; Santa Monica, CA USA
Pages 812-821 | Received 05 Mar 2012, Accepted 29 Apr 2012, Published online: 06 Jun 2012

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.